Market Tracker

09/01 6:05pm ET

Protalix Biotherapeutics Inc (NYSE MKT LLC:PLX)

2.60
Data as of Aug 29
 -0.01 / -0.38%
Today’s Change
2.35
Today|||52-Week Range
5.60
-33.16%
Year-to-Date

Today’s Trading

Previous close2.61
Today’s open2.75
Day’s range2.60 - 2.78
Volume881,453
Average volume (3 months)323,762
Market cap$243.5M
Dividend yield--
Data as of 4:01pm ET, 08/29/2014

Growth & Valuation

Earnings growth (last year)-130.77%
Earnings growth (this year)--
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)-66.56%
P/E ratioNM
Price/Sales31.21
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ESPREsperion Therapeutic...+0.05+0.32%
KMDAKamada Ltd+0.13+1.92%
FPRXFive Prime Therapeut...+0.09+0.78%
BTXBioTime Inc+0.13+4.36%
Data as of 4:00pm ET, 08/29/2014

Financials

Next reporting dateSeptember 3, 2014
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$11.5M
Annual profit (last year)-$27.8M
Net profit margin-241.38%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
David Aviezer
Chief Operating Officer
Tzvi Palash
Corporate headquarters
Carmiel, --

Forecasts